The ability of thymic histopathology to predict the long-term impact of thymectomy in non-thymomatous myasthenia gravis (NTMG) is mainly uncharted. We applied digital pathology to quantitatively characterize differences of thymic histology between early-onset (EOMG) and late-onset MG (LOMG) and to investigate the role of thymic changes for thymectomy outcomes in MG. We analyzed 83 thymic H&E slides from thymectomized NTMG patients, of which 69 had EOMG and 14 LOMG, using digital pathology open-access software QuPath. We compared the results to the retrospectively assessed clinical outcome at two years after thymectomy and at the last follow-up visit where complete stable remission and minimal use of medication were primary outcomes. The aut...
WOS: 000180995200021PubMed: 12559348Objective: Thymectomy remains as the optimal treatment of choice...
Background: Myasthenia gravis is an autoimmune disorder characterized by production of acetylcholine...
Objectives: Thymectomy is the treatment of choice for thymomatous myasthenia gravis (MG) for both on...
ObjectiveThe presence of ectopic thymic tissue has been considered one of the most significant predi...
Background It is popularly believed that myasthenia gravis (MG) patients show acetylcholine receptor...
OBJECTIVE: The presence of ectopic thymic tissue has been considered one of the most significant...
AbstractForty patients with myasthenia gravis underwent maximal thymectomy. Complete histologic stud...
Extended thymectomy has been considered the goal of surgery for myasthenia gravis (MG) mainly due to...
BackgroundIt is popularly believed that myasthenia gravis (MG) patients show acetylcholine receptor ...
International audienceThymomas are associated with a very high risk of developing Myasthenia Gravis ...
Publisher Copyright: © 2015 by Anete Zieda.Myasthenia gravis (MG) is an autoimmune disease character...
AbstractBackground and purposeThymectomy is generally accepted as the major option of treatment for ...
Background: The ability to distinguish between a normal thymus, thymic hyperplasia, and thymoma shou...
SYNOPSIS Fifty-four thymus glands removed surgically from patients with myasthenia gravis were exami...
ObjectivesThe objectives of this study were to compare the clinical features and the outcomes after ...
WOS: 000180995200021PubMed: 12559348Objective: Thymectomy remains as the optimal treatment of choice...
Background: Myasthenia gravis is an autoimmune disorder characterized by production of acetylcholine...
Objectives: Thymectomy is the treatment of choice for thymomatous myasthenia gravis (MG) for both on...
ObjectiveThe presence of ectopic thymic tissue has been considered one of the most significant predi...
Background It is popularly believed that myasthenia gravis (MG) patients show acetylcholine receptor...
OBJECTIVE: The presence of ectopic thymic tissue has been considered one of the most significant...
AbstractForty patients with myasthenia gravis underwent maximal thymectomy. Complete histologic stud...
Extended thymectomy has been considered the goal of surgery for myasthenia gravis (MG) mainly due to...
BackgroundIt is popularly believed that myasthenia gravis (MG) patients show acetylcholine receptor ...
International audienceThymomas are associated with a very high risk of developing Myasthenia Gravis ...
Publisher Copyright: © 2015 by Anete Zieda.Myasthenia gravis (MG) is an autoimmune disease character...
AbstractBackground and purposeThymectomy is generally accepted as the major option of treatment for ...
Background: The ability to distinguish between a normal thymus, thymic hyperplasia, and thymoma shou...
SYNOPSIS Fifty-four thymus glands removed surgically from patients with myasthenia gravis were exami...
ObjectivesThe objectives of this study were to compare the clinical features and the outcomes after ...
WOS: 000180995200021PubMed: 12559348Objective: Thymectomy remains as the optimal treatment of choice...
Background: Myasthenia gravis is an autoimmune disorder characterized by production of acetylcholine...
Objectives: Thymectomy is the treatment of choice for thymomatous myasthenia gravis (MG) for both on...